Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Nephrology

Understanding Isolated LMX1B-Associated Nephropathy

At a Glance

Isolated LMX1B-associated nephropathy, also called Nail-Patella-Like Renal Disease, is a genetic kidney disorder that can occur without nail or bone abnormalities. Protein in the urine, blood in the urine, kidney biopsy findings, and genetic testing help identify it.

If you have been told you have Nail-Patella-Like Renal Disease (NPLRD), or isolated LMX1B-associated nephropathy, you may feel like you are navigating a medical puzzle. This condition is a specific form of kidney disease caused by a change in the LMX1B gene [1][2]. While it shares a genetic cause with a more well-known condition called Nail-Patella Syndrome (NPS), the same gene can cause a spectrum of disease. In isolated nephropathy, no obvious extra-renal (non-kidney) features are present at the time of evaluation.

Why Your Experience Is Unique

For many people, the path to this diagnosis is long and confusing. Because your condition is “isolated,” you lack the classic physical hallmarks that doctors typically look for when they suspect a problem with the LMX1B gene. In classic Nail-Patella Syndrome, patients usually have visible abnormalities such as:

  • Nails: Discolored, split, or missing fingernails (especially the thumbnails) [3].
  • Knees: Small or missing kneecaps (patellae) [1].
  • Elbows: Problems fully extending or rotating the arms [3].
  • Pelvis: Small bony growths on the hip bones called iliac horns [3].

In NPLRD, these obvious physical signs are absent at evaluation [2]. Your condition appears limited strictly to the kidneys (nephropathy). Because doctors often rely on those external “clues” to point them toward the LMX1B gene, patients without them often undergo many tests before the correct cause is found [4][5].

The Role of the LMX1B Gene

The LMX1B gene provides instructions for a protein that acts as a transcriptional regulator during development [3]. It tells other genes when to turn on and off. In the kidneys, this protein is essential for the health of podocytes—specialized cells that act as the kidney’s filtration barrier [1][6].

When there is a pathogenic variant in this gene, the podocytes cannot maintain the filter properly. This leads to:

  • Proteinuria: Protein leaking into the urine [7].
  • Hematuria: Microscopic amounts of blood in the urine [2].
  • Scarring: Over time, the strain on the filters can lead to patterns of kidney scarring, such as FSGS (Focal Segmental Glomerulosclerosis) [8][7].

Understanding the Rarity

You may hear the number “1 in 50,000” mentioned during your appointments. This is the estimated frequency of classic Nail-Patella Syndrome [4]. However, this number does not accurately describe your situation. Because NPLRD is often misdiagnosed or overlooked due to the lack of physical signs, we do not yet know exactly how common the isolated renal form of the disease truly is [1].

How Diagnosis Usually Happens

Since you lack the obvious physical signs, the diagnosis often comes through a kidney biopsy and genetic testing. On a biopsy, a doctor might see specific structural changes in the Glomerular Basement Membrane (GBM), the “mesh” that filters your blood [2][9].

One supportive finding sometimes seen under a high-powered electron microscope is the buildup of type III collagen within the kidney’s filters [2][7]. While this is a useful clue that points toward the LMX1B gene, it is not required for diagnosis, and its absence does not rule out the condition [2].

Ultimately, genetic testing is used to confirm that an LMX1B mutation is the cause of your kidney disease [7][10]. However, finding a variant of uncertain significance (VUS) does not establish a diagnosis, and genetic counseling is important to interpret the results.

Common questions in this guide

What is Nail-Patella-Like Renal Disease?
Nail-Patella-Like Renal Disease, or NPLRD, is a kidney disorder associated with a pathogenic variant in the LMX1B gene. It can affect the kidney’s filtration cells even when no obvious nail, kneecap, elbow, or pelvic abnormalities are found at evaluation.
Can I have an LMX1B-related kidney disorder without nail or bone changes?
Yes. In NPLRD, the disease may appear limited to the kidneys, so the classic features of Nail-Patella Syndrome may be absent when you are evaluated. A careful physical examination can still look for subtle signs.
What kidney problems can an LMX1B variant cause?
An LMX1B variant can impair podocytes, the specialized cells that help filter blood in the kidneys. This may lead to protein in the urine, microscopic blood in the urine, and over time patterns of scarring such as focal segmental glomerulosclerosis, or FSGS.
How is isolated LMX1B-associated nephropathy diagnosed?
Diagnosis usually combines a clinical examination, kidney biopsy, and genetic testing. A biopsy may show changes in the glomerular basement membrane, and type III collagen can be a supportive clue, but that finding is not required. A disease-causing LMX1B variant supports the diagnosis, while a variant of uncertain significance alone does not establish it.
Does finding type III collagen prove that I have NPLRD?
No. Type III collagen in the kidney’s filtration structures can support suspicion of an LMX1B-related disorder, but it is not required for diagnosis. Its absence also does not rule out NPLRD.
Is isolated NPLRD as common as classic Nail-Patella Syndrome?
The often-cited estimate of 1 in 50,000 refers to classic Nail-Patella Syndrome. The true frequency of isolated NPLRD is not known because it may be missed or misdiagnosed when external features are absent.
Should my family members get genetic counseling or testing?
Genetic counseling can help explain your LMX1B result, determine whether it is disease-causing, and discuss appropriate options for relatives. Testing decisions should be based on the specific variant and family history with guidance from a genetics professional.

Get notified when new evidence is published on Nail-patella-like renal disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (10)
  1. 1

    Spectrum of LMX1B mutations: from nail-patella syndrome to isolated nephropathy.

    Harita Y, Kitanaka S, Isojima T, et al.

    Pediatric nephrology (Berlin, Germany) 2017; (32(10)):1845-1850 doi:10.1007/s00467-016-3462-x.

    PMID: 27450397
  2. 2

    Clinical and histological findings of autosomal dominant renal-limited disease with LMX1B mutation.

    Konomoto T, Imamura H, Orita M, et al.

    Nephrology (Carlton, Vic.) 2016; (21(9)):765-73 doi:10.1111/nep.12666.

    PMID: 26560070
  3. 3

    Nail-Patella syndrome with early onset end-stage renal disease in a child with a novel heterozygous missense mutation in the LMX1B homeodomain: A case report.

    Carinelli S, Blanco OA, Perdomo-Ramirez A, Claverie-Martin F

    Biomedical reports 2020; (13(5)):49 doi:10.3892/br.2020.1356.

    PMID: 32963778
  4. 4

    Orthopedic manifestations and management of nail-patella syndrome: a narrative review.

    Beaugé A, Sbampato V, Vazquez O, et al.

    Frontiers in pediatrics 2026; (14()):1744875 doi:10.3389/fped.2026.1744875.

    PMID: 41716707
  5. 5

    Nail-patella syndrome with nephropathy in a de novo LMX1B mutation: triangular lunula of the thumb and lack of finger creases as clues.

    Banno Y, Ikemiyagi M, Hamada R, et al.

    Pediatric nephrology (Berlin, Germany) 2024; (39(9)):2627-2631 doi:10.1007/s00467-024-06344-2.

    PMID: 38478172
  6. 6

    Dysregulation of WTI (-KTS) is Associated with the Kidney-Specific Effects of the LMX1B R246Q Mutation.

    Hall G, Lane B, Chryst-Ladd M, et al.

    Scientific reports 2017; (7()):39933 doi:10.1038/srep39933.

    PMID: 28059119
  7. 7

    Myelin bodies in LMX1B-associated nephropathy: potential for misdiagnosis.

    Lei L, Oh G, Sutherland S, et al.

    Pediatric nephrology (Berlin, Germany) 2020; (35(9)):1647-1657 doi:10.1007/s00467-020-04564-w.

    PMID: 32356190
  8. 8

    Whole-Exome Sequencing Solved over 2-Decade Kidney Disease Enigma.

    Isaranuwatchai S, Chanakul A, Ittiwut C, et al.

    Nephron 2021; (145(3)):311-316 doi:10.1159/000514293.

    PMID: 33725694
  9. 9

    LMX1B-Associated Nephropathy With Type III Collagen Deposition in the Glomerular and Tubular Basement Membranes.

    Andeen NK, Schleit J, Blosser CD, et al.

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2018; (72(2)):296-301 doi:10.1053/j.ajkd.2017.09.023.

    PMID: 29246420
  10. 10

    Genomic medicine for kidney disease.

    Groopman EE, Rasouly HM, Gharavi AG

    Nature reviews. Nephrology 2018; (14(2)):83-104 doi:10.1038/nrneph.2017.167.

    PMID: 29307893

This page is for informational purposes only and does not constitute medical advice. Ask your nephrologist, genetic counselor, or pathologist to interpret your biopsy and LMX1B results in your personal context.